BLOCK: Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course
Study Details
Study Description
Brief Summary
The objective of this study is to describe in a cohort of cardiac surgery patients the use of beta-blockers before surgery and their maintenance or withdraw according to international recommendations in order to compare patients who receive a beta-blocker with maintenance during the surgical period (international recommendation) to those for whom prescription and maintenance are not respected. Patients are treated according to standard practice and this protocol does not change patient management. No additional information or data is required by the study other than the data usually collected in the patient record (drug treatment, medical history, operating data, postoperative data, complications, length of stay).
The objectives of this research are :
-
To evaluate the proportion of patients receiving beta-blocker treatment prior to cardiac surgery.
-
To evaluate the proportion of patients receiving beta-blocker treatment before cardiac surgery and complying with international recommendations for its maintenance/stop in perioperative cardiac surgery.
-
To evaluate the incidence of complications and length of hospital stay in patients receiving beta-blockers based on compliance or non-compliance with recommendations.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No beta-blocker Patient do no treat with beta-blocker before the surgery |
Other: collection of the allocated treatment
collection of the allocated treatment
Other: collection of medical complications
collection of medical complications
|
| Beta blocker Patient treat with beta-blocker in accordance to international guidelines |
Other: collection of the allocated treatment
collection of the allocated treatment
Other: collection of medical complications
collection of medical complications
|
| Beta blocker2 Patient treat with beta-blocker without respect of international guidelines |
Outcome Measures
Primary Outcome Measures
- Number of patients treated with beta-blocker in accordance with international guidelines [7 days]
Number of patients treated with beta-blocker in accordance with international guidelines
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Major patient ≥ 18 years
-
Patient operated cardiac surgery with cardiopulmonary bypass
-
Patients who have given oral consent to participate after full information
Exclusion Criteria:
- Off pump cardiac surgery
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Chu Dijon Bourogne | Dijon | France | 21000 |
Sponsors and Collaborators
- Centre Hospitalier Universitaire Dijon
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Guinot 2021